Artwork for AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF
00:00:00 / 00:13:33